rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway-Reference-Cited by-同舟云学术

rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway

Published:2020-09-28 Issue:2 Volume:39 Page:377-385
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Yu Ping,Wu Rui,Zhou Zunchun,Zhang Xin,Wang Ruoshu,Wang Xueting,Lin Sen,Wang Jihong^ORCID,Lv Li^ORCID

Funder

National Natural Science Foundation of China

Liaoning Province Key Research and Development Program

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-020-01008-y.pdf

Reference35 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

2. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144(8):1941–1953. https://doi.org/10.1002/ijc.31937

3. Sia D, Villanueva A, Friedman SL, Llovet JM (2017) Liver Cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152(4):745–761. https://doi.org/10.1053/j.gastro.2016.11.048

4. Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S (2017) NCCN guidelines insights: Hepatobiliary cancers, version 1.2017. J Natl Compr Cancer Netw 15(5):563–573. https://doi.org/10.6004/jnccn.2017.0059

5. Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD (2019) Guidelines insights: Hepatobiliary cancers, version 2.2019. J Natl Compr Cancer Netw 17(4):302–310. https://doi.org/10.6004/jnccn.2019.0019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-Bromopalmitate inhibits malignant behaviors of HPSCC cells by hindering the membrane location of Ras protein;Experimental Biology and Medicine;2023-12-30

2. rAj-Tspin, a novel peptide from Apostichopus japonicus, exerts anti-hepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway;2023-08-17

3. Cyclopeptide-based Anti-liver Cancer Agents: A Mini-review;Protein & Peptide Letters;2023-03

4. Integrins in human hepatocellular carcinoma tumorigenesis and therapy;Chinese Medical Journal;2023-02-05

5. Recent advances in sea cucumber peptide: Production, bioactive properties, and prospects;Food Frontiers;2022-12-31